The Concept of Intergenerational Service-Learning in MBA Marketing Courses

In teaching and learning, instructors are often faced with finding ‘real world’ applications to enrich their teaching to facilitate a more practice-related learning experience. Particularly students having five or more years of experience, upon enrolling in an MBA program, appear to find it hard to connect with theories, models and abstract thinking in their coursework. This paper outlines an approach of “intergenerational teaching and learning” in an MBA Marketing course at a University in New Zealand. The instructor facilitated a service-learning scenario in which MBA Alumni were project sponsors for current MBA students. Approximately 40 MBA students executed these client-sponsored projects in groups of four to five individuals. This paper describes the teaching and learning concept, discusses potential learning experiences and suggests potential improvements for the next iteration

Arterial Thrombosis in Patients with Cancer.

Cancer is a common cause of morbidity and mortality in the USA. While the association between venous thrombosis and malignancy is well established, arterial thrombosis has more recently been recognized as a serious complication of cancer and certain chemotherapeutic agents. This review aims to summarize the most recent literature regarding the incidence and risk factors for cancer-related arterial thrombosis, understand the pathophysiologic mechanisms of thrombosis, and highlight the specific diagnostic and treatment considerations relevant to cancer patients.Based on a recent study looking at the Surveillance, Epidemiology, and End Results (SEER) database, the incidence of arterial thromboembolic events (ATEs) in patients with cancer at 6 months is 4.7%; the presence of an ATE is predictive of worse outcomes. Certain drugs such as platinum-based agents, vascular endothelial growth factor inhibitors, tyrosine kinase inhibitors, and taxanes have been associated with high rates of ATEs. Increased platelet reactivity appears crucial to development of arterial thrombosis in cancer patients. Cancer patients have an increased risk of arterial thrombosis that is likely due to both a cancer-associated procoagulant state as well as the adverse effects of certain chemotherapeutic agents. Treatment of arterial thromboembolism in cancer patients typically requires a multidisciplinary approach in part due to high rates of thrombocytopenia and stent thrombosis in the setting of percutaneous interventions. More studies are needed to investigate optimal prophylaxis, surveillance strategies, and treatments of cancer-related arterial thromboembolic disease